<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04910620</url>
  </required_header>
  <id_info>
    <org_study_id>201912029RSA</org_study_id>
    <nct_id>NCT04910620</nct_id>
  </id_info>
  <brief_title>The Evaluation of TCI378 and TCI507 Probiotics on Weight-lowering Efficacy in Adults</brief_title>
  <official_title>The Evaluation of TCI378 and TCI507 Probiotics on Weight-lowering Efficacy in Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obesity is a serious global public health issue. Many reports have showed that the use of&#xD;
      appropriate probiotics can bring benefits to the health of the host and promote the balance&#xD;
      of gut microbiota. Clinical experimental data show that the supplement of probiotics can help&#xD;
      regulate gut function and weight control, and etc.&#xD;
&#xD;
      TCI378 (Lactobacillus plantarum TCI378) is a probiotic extracted from Korean kimchi, and&#xD;
      TCI507 (Lactobacillus plantarum TCI507) is a probiotic extracted from the oranges peels.&#xD;
      These two strains of probiotics have been verified by in vitro experiments to have the effect&#xD;
      of hydrolyzing bile salts, inhibition of the production of fat cells. Therefore, we want to&#xD;
      evaluate whether the probiotics TCI308 and TCI507 have effects on reduction of body weight.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 15, 2021</start_date>
  <completion_date type="Anticipated">June 14, 2024</completion_date>
  <primary_completion_date type="Anticipated">June 14, 2024</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate whether the probiotics TCI378 (Lactobacillus plantarum TCI378) and TCI507 (Lactobacillus plantarum TCI507) have effect on reduction of body weight.</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Weight Reduction</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo without TCI378 and TCI507</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TCI378</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>probiotics TCI378 (Lactobacillus plantarum TCI378)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TCI507</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TCI507 (Lactobacillus plantarum TCI507)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo only</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TCI378</intervention_name>
    <description>TCI378 (Lactobacillus plantarum TCI378)</description>
    <arm_group_label>TCI378</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TCI507</intervention_name>
    <description>TCI507 (Lactobacillus plantarum TCI507)</description>
    <arm_group_label>TCI507</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adults between the ages of 20 and 65 who are willing to sign the consent form of the&#xD;
             subject.&#xD;
&#xD;
          2. For those with BMI ≥ 24, men's body fat ≥ 25%, women's body fat ≥ 30%&#xD;
&#xD;
          3. Those who are not pregnant and are willing to cooperate with contraception during the&#xD;
             trial period.&#xD;
&#xD;
          4. Those who have no history of cardiovascular disease, organ transplantation, epilepsy&#xD;
             or convulsions, liver and kidney disease, malignant tumors, endocrine disease, mental&#xD;
             disease, alcohol or drug abuse, and other major organic diseases (according to medical&#xD;
             history).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnant women, people with a history of cardiovascular disease, organ&#xD;
             transplantation, epilepsy or convulsions, liver and kidney disease, malignant tumors,&#xD;
             endocrine diseases, mental illness, alcohol or drug abuse, and other major organic&#xD;
             diseases (according to medical history).&#xD;
&#xD;
          2. Those who had undergone major surgery or bariatric surgery (according to medical&#xD;
             history).&#xD;
&#xD;
          3. Currently or within 3 months before participating in the screening, those subjects&#xD;
             used drugs that can affect body fat or increase weight significantly, such as systemic&#xD;
             corticosteroids, tricyclic antidepressants, atypical psychiatric drugs, and mood&#xD;
             stability Drugs (according to medical history).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jyh-Ming Liou</last_name>
    <phone>23123456</phone>
    <phone_ext>63541</phone_ext>
    <email>jyhmingliou@gmail.com</email>
  </overall_contact>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 27, 2021</study_first_submitted>
  <study_first_submitted_qc>May 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 2, 2021</study_first_posted>
  <last_update_submitted>May 27, 2021</last_update_submitted>
  <last_update_submitted_qc>May 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

